LY2623091 is a potent glucocorticoid receptor antagonist known for its role in modulating mineralocorticoid signaling. This compound demonstrates significant potential in the treatment of refractory hypertension by inhibiting the action of glucocorticoids, thereby addressing hypertension mechanisms. Additionally, LY2623091 exhibits CYP3A4-dependent clearance, presenting possibilities for synergistic therapeutic strategies when used in conjunction with CYP3A4 inhibitors in research applications.
LY2623091 is a potent glucocorticoid receptor antagonist known for its role in modulating mineralocorticoid signaling. This compound demonstrates significant potential in the treatment of refractory hypertension by inhibiting the action of glucocorticoids, thereby addressing hypertension mechanisms. Additionally, LY2623091 exhibits CYP3A4-dependent clearance, presenting possibilities for synergistic therapeutic strategies when used in conjunction with CYP3A4 inhibitors in research applications.
This calculator helps you calculate mass of compound based on solution concentration, volume and molecular weight in a specific solution using the formula:
